EXACT Sciences Corp. (EXAS)

106.71
NASDAQ : Health Technology
Prev Close 108.69
Day Low/High 106.06 / 109.27
52 Wk Low/High 53.06 / 123.99
Avg Volume 1.50M
Exchange NASDAQ
Shares Outstanding 129.49M
Market Cap 14.07B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

I Am Going to Quote You a Bunch of Statistics Tonight

Some are going to confirm the bearish bias.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AES, ALIM, APPS, EXAS, INVH, LBRDA, LBRDK, LLY, TLK Downgrades: CTT, DRH, HA, MTDR, ORIT, RNG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Exact Sciences Stock: Buy at What Level?

Exact Sciences Stock: Buy at What Level?

Our strategy on EXAS shares after the company's latest earnings.

Costco, Tellurian, Exact Sciences: 'Mad Money' Lightning Round

Costco, Tellurian, Exact Sciences: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Costco, Tellurian, Exact Sciences, XPO Logistics, Align Technology and more.

Don't Write Off FANG: Cramer's 'Mad Money' Recap (Wednesday 10/31/18)

Don't Write Off FANG: Cramer's 'Mad Money' Recap (Wednesday 10/31/18)

Jim Cramer says investors need to remember how terrific these companies are, and why they can't be written off.

Raytheon, Northrop Grumman, Zuora: 'Mad Money' Lightning Round

Raytheon, Northrop Grumman, Zuora: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Raytheon, Northrop Grumman, Zuora, Exact Sciences.

Apple's Trillion-Dollar Market Cap: Cramer's 'Mad Money' Recap (Thur 8/2/18)

Apple's Trillion-Dollar Market Cap: Cramer's 'Mad Money' Recap (Thur 8/2/18)

This trillion-dollar level is so meaningful, Jim Cramer says, because Apple may be the first company to get here, but it won't be the last. Get ready.

EXACT Sciences Corp. Larger Than S&P 500 Component Qorvo

EXACT Sciences Corp. Larger Than S&P 500 Component Qorvo

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Qorvo Inc , according to The Online Investor.

Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer

Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer

ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.

3 'Strong Buy' Healthcare Stocks Poised to Surge

3 'Strong Buy' Healthcare Stocks Poised to Surge

Here are the top healthcare bets ticking all the boxes for analysts.

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.

Notable Friday Option Activity: EXAS, GTLS, CARB

Notable Friday Option Activity: EXAS, GTLS, CARB

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. , where a total volume of 12,345 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares).

EXACT Sciences Corp. Larger Than S&P 500 Component Tripadvisor

EXACT Sciences Corp. Larger Than S&P 500 Component Tripadvisor

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Tripadvisor Inc , according to The Online Investor.

EXACT Sciences: Wait For a Better Buying Opportunity

EXACT Sciences: Wait For a Better Buying Opportunity

The stock still looks vulnerable to further declines from a technical perspective.

Exact Sciences: Cramer's Top Takeaways

Exact Sciences: Cramer's Top Takeaways

Kevin Conroy, chairman and CEO of Exact Sciences, tells Jim Cramer about his company's expansion plans for cancer screening tests.

Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)

Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)

From global growth and bonds to index funds, Jim Cramer explains why stocks keep going up, giving the Dow and Nasdaq their best start to the new year since 2006.

Exact Sciences, Cognizant Technology, MetLife: 'Mad Money' Lightning Round

Exact Sciences, Cognizant Technology, MetLife: 'Mad Money' Lightning Round

Jim Cramer is bullish on Exact Sciences, Cognizant Technology, MetLife, JPMorgan Chase and more.

Sentiment Is Everything Right Now: Cramer's 'Mad Money' Recap (Thursday 11/2/17)

Sentiment Is Everything Right Now: Cramer's 'Mad Money' Recap (Thursday 11/2/17)

Sentiment is critical to the next market move, says Jim Cramer. A little negativity is great news for the bulls.

Noteworthy Monday Option Activity: EXAS, SHAK, ETM

Noteworthy Monday Option Activity: EXAS, SHAK, ETM

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. , where a total volume of 9,758 contracts has been traded thus far today, a contract volume which is representative of approximately 975,800 underlying shares (given that every 1 contract represents 100 underlying shares).

Short Interest Drops 32.5% For EXAS

Short Interest Drops 32.5% For EXAS

The most recent short interest data has been released for the 09/29/2017 settlement date, which shows a 5,295,292 share decrease in total short interest for EXACT Sciences Corp. , to 10,994,802, a decrease of 32.51% since 09/15/2017.

Short Seller's Critique of Shopify Is 'All Smoke and No Fire'

Short Seller's Critique of Shopify Is 'All Smoke and No Fire'

Analysts, consultants and Shopify users came to the company's defense when TheStreet reached out to them.

Short Interest Declines 11.3% For EXAS

Short Interest Declines 11.3% For EXAS

The most recent short interest data has been released for the 09/15/2017 settlement date, which shows a 2,075,458 share decrease in total short interest for EXACT Sciences Corp. , to 16,290,094, a decrease of 11.30% since 08/31/2017.

Short Interest Falls 11.2% For EXAS

Short Interest Falls 11.2% For EXAS

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 2,304,856 share decrease in total short interest for EXACT Sciences Corp. , to 18,237,019, a decrease of 11.22% since 07/14/2017.

Exact Sciences' Estimates Raised on Increased Contracts With Healthcare Providers

Exact Sciences' Estimates Raised on Increased Contracts With Healthcare Providers

Venture Capital firm Benchmark reiterated its 'Buy' rating on the stock and $50 price target.

Short Interest Moves 10% Lower For EXAS

The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 2,463,634 share decrease in total short interest for EXACT Sciences Corp. , to 22,030,168, a decrease of 10.06% since 05/31/2017.

Exact Sciences Stock Falls on Secondary Stock Sale

Exact Sciences Stock Falls on Secondary Stock Sale

The secondary offering, to be underwritten by Jefferies, Bank of America/Merrill Lynch and Robert W. Baird, would offer 7 million shares.

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals

Plus more from the biotechnology world on Wednesday, June 7.

Exact Sciences: Cramer's Top Takeaways

Exact Sciences: Cramer's Top Takeaways

Kevin Conroy, chairman, president and CEO at Exact Sciences, tells Jim Cramer about his company's non-invasive test for colon cancer.

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Jim Cramer has the game plan for next week, including earnings from Thor Industries and HD Supply.

Blackberry, Exact Sciences, Splunk, Freeport-McMoRan: 'Mad Money' Lightning Round

Blackberry, Exact Sciences, Splunk, Freeport-McMoRan: 'Mad Money' Lightning Round

Jim Cramer focuses on Blackberry, Exact Sciences, Splunk, Freeport-McMoRan and more.

TheStreet Quant Rating: C- (Hold)